T. Shaw

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

Paul P. Tak, William F. C. Rigby, Andrea Rubbert‐Roth et al. · Annals of the Rheumatic Diseases · 2010 · 300 citations · Full text

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

Andrea Rubbert‐Roth, P. P. Tak, Cristiano A. F. Zerbini et al. · Lara D. Veeken · 2010 · 182 citations · Full text

Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients

Mark C. Genovese, FC Breedveld, P. Emery et al. · Annals of the Rheumatic Diseases · 2009 · 87 citations · Full text

Rituximab (RTX) plus Methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomised, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-score)

Charles Peterfy, Paul Emery, P. P. Tak et al. · Annals of the Rheumatic Diseases · 2011 · 18 citations

THU0197 SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Stanley Cohen, Ronald van Vollenhoven, Jeffrey R. Curtis et al. · Annals of the Rheumatic Diseases · 2020 · 15 citations · Full text